Contact this trialFirst, we need to learn more about you.
EGFR Inhibitor
SAR444245 + Anticancer Therapies for Gastrointestinal Cancer
Recruiting1 awardPhase 2
Duarte, California
This trial is a phase 2 study investigating the efficacy of SAR444245 in combination with other cancer treatments for patients with advanced gastrointestinal cancer. The study is composed of four sub-studies, each investigating the combination of SAR444245 with a different treatment for a different type of gastrointestinal cancer. The primary outcome measure for each sub-study is the percentage of patients experiencing an objective response.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.